Two Sigma Securities’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Two Sigma Securities's ONCE Position: Q4 2019 in Review
Two Sigma Securities sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 3,429 shares — an estimated $333K sold.
Two Sigma Securities first reported a position in ONCE in Q3 2019 and held it in 1 quarter. The position peaked at $333K in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Two Sigma Securities reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Two Sigma Securities sold 3,429 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $333K.
- Two Sigma Securities first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
- Two Sigma Securities's Spark Therapeutics, Inc. Common Stock position peaked at $333K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Two Sigma Securities's 13F filing for Q4 2019, filed 14 Feb 2020.